Englander Institute for Precision Medicine

Cancer Immunotherapy with CDK7 Inhibitors.

TitleCancer Immunotherapy with CDK7 Inhibitors.
Publication TypeJournal Article
Year of Publication2020
AuthorsPetroni G, Galluzzi L
JournalTrends Cancer
Volume6
Issue5
Pagination361-363
Date Published2020 May
ISSN2405-8025
KeywordsGenomic Instability, Humans, Immunotherapy, Neoplasms
Abstract

Recent findings demonstrate that pharmacological cyclin-dependent kinase 7 (CDK7) inhibitors can evoke anticancer immunity upon genomic destabilization of neoplastic cells. Besides adding CDK7 to the expanding list of cell cycle proteins that impinge on immune regulation, these results support the value of aggravating genomic instability in cancer cells to enable immunological disease control.

DOI10.1016/j.trecan.2020.02.005
Alternate JournalTrends Cancer
PubMed ID32348731

Weill Cornell Medicine Englander Institute for Precision Medicine 413 E 69th Street
Belfer Research Building
New York, NY 10021